tiprankstipranks
Trending News
More News >
Cytek Biosciences (CTKB)
NASDAQ:CTKB

Cytek Biosciences (CTKB) Revenue

Compare
55 Followers

Cytek Biosciences Revenue

Cytek Biosciences had a revenue of 33.65M in the quarter ending Dec 31, 2024, with -34.66%. This bring the company's revenue in the last twelve months to 176.63M, Increased -12.22%. In the fiscal year ending Dec 31, 2024, Cytek Biosciences had annual revenue of 200.45M with 3.85% growth.
Revenue (ttm)
176.63M
Revenue Growth
3.85%
P/S Ratio
2.25
Revenue/Employee
$309,341
Employees
648
Market Cap
$450.90M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024200.45M7.44M+3.85%
Dec 31, 2023193.01M28.98M+17.67%
Dec 31, 2022164.04M36.09M+28.20%
Dec 31, 2021127.95M35.11M+37.82%
Dec 31, 202092.84M34.96M+60.39%
Dec 31, 201957.88M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis